AUSTIN, TX / ACCESS Newswire / September 10, 2025 / Genprex, Inc.'s President and Chief Executive Officer, Ryan Confer, will present at the Investor Summit Virtual on September 16, 2025, offering investors an inside look at the company's growth strategies and market opportunities.
About Genprex, Inc.
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches.
Event Details
Event: Q3 Investor Summit
Presentation Date & Time: September 16 | 2:00 PM ET
Location: Webcast Link
Conference Overview and Structure
The Investor Summit is an exclusive virtual event for investors specializing in small and microcap stocks. Attendees will:
Hear directly from company executives about key strategies and milestones
Learn from industry experts and thought leaders
Explore opportunities in the microcap market
This quarter's event emphasizes undervalued MicroCap companies with strong growth catalysts, providing investors with a unique platform for discovery and engagement.
Investor Registration:
Investors can register for free using the link below: https://investorsummitgroup.fillout.com/t/8CZGk3gSQbus
Sponsors:
ACCESS Newswire | PCG Advisory | QuoteMedia | AGP | MZ Group
Media Contact:
For more information, please visit https://investorsummitgroup.com/ or contact johnna-mae@investorsummitgroup.com
SOURCE: Genprex, Inc.
View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/ryan-confer-president-and-chief-executive-officer-of-genprex-inc.-to-1070980
